Literature DB >> 10754385

Investigations of the effects of ethanol on warfarin binding to human serum albumin.

C E Ha1, C E Petersen, D S Park, K Harohalli, N V Bhagavan.   

Abstract

Ethanol effects on warfarin binding to human serum albumin (HSA) have been studied by equilibrium dialysis and fluorescence methods at pH 7.4 in phosphate-buffered saline at 37 degrees C. In the presence of various amounts of ethanol fluorescence intensity of bound warfarin decreased significantly but this intensity reduction was not solely from displacement of bound warfarin from HSA. By comparing fluorescence and equilibrium dialysis data we concluded that fluorescence intensity reduction of warfarin was mainly the result of changes in the surrounding environment of the warfarin binding site by ethanol interaction with HSA and that displacement of bound warfarin was not significant compared to the fluorescence intensity changes. The dissociation constant of warfarin binding to HSA decreased with an increasing amount of ethanol. From the changes in fluorescence intensity upon warfarin binding to HSA with the presence of ethanol ranging from 0 to 5.0% the following dissociation constants (Kd) were determined: 0% ethanol 5.39 +/- 0.2 microM, 0.1% ethanol 5.86 +/- 0.1 microM, 0.3% ethanol 5.83 +/- 0.2 microM, 0.5% ethanol 6.76 +/- 0.1 microM, 1% ethanol 7.01 +/- 0.1 microM, 3% ethanol 9.9 +/- 0.7 microM, 5% ethanol 13.01 +/- 0.1 microM. From the equilibrium dialysis with the same ranges of ethanol presence the following Kd values were obtained: 0% ethanol 6. 62 +/- 1.6 microM, 0.1% ethanol 6.81 +/- 1.1 microM, 0.3% ethanol 8. 26 +/- 2.5 microM, 0.5% ethanol 8.86 +/- 1.9 microM, 1% ethanol 11. 01 +/- 4.2 microM, 3% ethanol 20.75 +/- 2.4 microM, 5% ethanol 21.67 +/- 2.2 microM. The results suggest that warfarin bound to HSA was displaced by ethanol. These data indicate that ethanol influence on warfarin binding to HSA may alter the pharmacokinetics of warfarin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754385     DOI: 10.1007/bf02256617

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  8 in total

1.  Molecular cloning, expression, and cytokinin (6-benzylaminopurine) antagonist activity of peanut (Arachis hypogaea) lectin SL-I.

Authors:  Monika Pathak; Bharat Singh; Amit Sharma; Praveen Agrawal; Santosh B Pasha; Hasi R Das; Rakha H Das
Journal:  Plant Mol Biol       Date:  2006-08-29       Impact factor: 4.076

2.  Interpreting physicochemical experimental data sets.

Authors:  Nicola Colclough; Mark C Wenlock
Journal:  J Comput Aided Mol Des       Date:  2015-06-09       Impact factor: 3.686

3.  Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis.

Authors:  Edith A Nutescu; Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

4.  Factors affecting the maintenance stable warfarin dosage in Hong Kong Chinese patients.

Authors:  Vivian W Y Lee; Joyce H S You; Kenneth K C Lee; T S Chau; Mary M Y Waye; Gregory Cheng
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

5.  Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.

Authors:  Truman J Milling; Jennifer Frontera
Journal:  Am J Manag Care       Date:  2017-04       Impact factor: 2.229

6.  New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism.

Authors:  Michael J Kimzey; Hussein N Yassine; Brent M Riepel; George Tsaprailis; Terrence J Monks; Serrine S Lau
Journal:  Chem Biol Interact       Date:  2010-10-08       Impact factor: 5.192

7.  Alcohol binding in the C1 (C1A+C1B) domain of protein kinase C epsilon.

Authors:  Satyabrata Pany; Joydip Das
Journal:  Biochim Biophys Acta       Date:  2015-07-22

8.  Impact of body mass index on 90-day warfarin requirements: a retrospective chart review.

Authors:  Bolanle M Soyombo; Ashley Taylor; Christopher Gillard; Candice Wilson; Janel Bailey Wheeler
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.